about
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-medi...
Read More
1.33
-0.03
(-2.21%)
845.4K
XNAS Volume
XNAS 11 Aug, 2025 2:51 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Cabaletta Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..